FDA Halts Elevidys Shipments

News

sarepta therapeutics, Elevidys

FDA allows Sarepta to resume some Elevidys shipments

The company can again ship the Duchenne gene therapy for patients who can still walk, following a one-week pause triggered by safety concerns.

· 9h · on MSN

Sarepta resumes shipping of gene therapy Elevidys to patients who can walk

· 10d · on MSN

FDA to Ask Sarepta to Halt Elevidys Shipments After Deaths

10h

Sarepta Therapeutics to Lift Pause on Shipments of Duchenne Treatment Elevidys

Sarepta Therapeutics said the Food and Drug Administration informed the company it can lift a voluntary pause on shipments of Elevidys for ambulatory patients with Duchenne. The company said Monday ...

BioPharma Dive7d

Sarepta stops Elevidys shipments after standoff with FDA

Company CEO Doug Ingram said the pause was necessary for Sarepta to maintain a "productive and positive working relationship" ...

Sarepta under pressure: FDA requests halt of Elevidys shipments

Sarepta Therapeutics (SRPT) stock is in focus after the US Food and Drug Administration (FDA) asked the company to halt ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results